Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Ryan

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
The Oncologist|February 12, 2020
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and EtoposideEric Lu, Christopher W Ryan, Solange Bassale, et al.
The Journal of Urology|August 8, 2006
Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancerChristopher W Ryan, Dezheng Huo, Laurence M Demers, et al.
The Journal of Urology|August 12, 2005
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II studyNatasha M Tiffany, Christopher W Ryan, Mark Garzotto, et al.
Ecology and Evolution|February 7, 2022
Novel hair snare and genetic methods for non-invasive bobcat detectionThomas F Rounsville, Richard E Rogers, Amy B Welsh, et al.
Investigational New Drugs|December 17, 2009
A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinomaChristopher W Ryan, Jacqueline Vuky, Joseph S Chan, et al.
Surgery|November 8, 2003
Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) eraPeter C Wu, Alex Langerman, Christopher W Ryan, et al.
Anti-Cancer Drugs|December 18, 2009
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapyTomasz M Beer, Charles Ryan, Joshi Alumkal, et al.
Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2002
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancerChristopher W Ryan, Everett E Vokes, Nicholas J Vogelzang, et al.
American Journal of Clinical Oncology|February 3, 2005
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancerSupriya Gupta, Ann M Mauer, Christopher W Ryan, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
The Oncologist|February 12, 2020
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and EtoposideEric Lu, Christopher W Ryan, Solange Bassale, et al.
The Journal of Urology|August 8, 2006
Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancerChristopher W Ryan, Dezheng Huo, Laurence M Demers, et al.
The Journal of Urology|August 12, 2005
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II studyNatasha M Tiffany, Christopher W Ryan, Mark Garzotto, et al.
Ecology and Evolution|February 7, 2022
Novel hair snare and genetic methods for non-invasive bobcat detectionThomas F Rounsville, Richard E Rogers, Amy B Welsh, et al.
Investigational New Drugs|December 17, 2009
A phase II study of everolimus in combination with imatinib for previously treated advanced renal carcinomaChristopher W Ryan, Jacqueline Vuky, Joseph S Chan, et al.
Surgery|November 8, 2003
Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) eraPeter C Wu, Alex Langerman, Christopher W Ryan, et al.
Anti-Cancer Drugs|December 18, 2009
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapyTomasz M Beer, Charles Ryan, Joshi Alumkal, et al.
Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2002
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancerChristopher W Ryan, Everett E Vokes, Nicholas J Vogelzang, et al.
American Journal of Clinical Oncology|February 3, 2005
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancerSupriya Gupta, Ann M Mauer, Christopher W Ryan, et al.
Pageof 12